Nobuyuki Oshima - Search Results

Year	Number of Results
2015	1
2016	2
2018	1
2019	1
2021	2
2022	4
2023	2
2024	1

1

Safety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine, V116, in Japanese healthy adults: A Phase I study.

Haranaka M, Yono M, Kishino H, Igarashi R, Oshima N, Sawata M, Platt HL. Haranaka M, et al. Among authors: oshima n. Hum Vaccin Immunother. 2023 Aug 1;19(2):2228162. doi: 10.1080/21645515.2023.2228162. Hum Vaccin Immunother. 2023. PMID: 37389808 Free PMC article. Clinical Trial.

2

Efficacy and safety of tedizolid for the treatment of ventilated gram-positive hospital-acquired or ventilator-associated bacterial pneumonia in Japanese patients: Results from a subgroup analysis of a phase 3, randomized, double-blind study comparing tedizolid and linezolid.

Mikamo H, Nagashima M, Kusachi S, Fujimi S, Oshima N, De Anda C, Takase A. Mikamo H, et al. Among authors: oshima n. J Infect Chemother. 2022 Sep;28(9):1235-1241. doi: 10.1016/j.jiac.2022.04.027. Epub 2022 Jun 16. J Infect Chemother. 2022. PMID: 35718656 Free article. Clinical Trial.

3

Investigations into the Potential of Using Open Source CFD to Analyze the Differences in Hemodynamic Parameters for Aortic Dissections (Healthy versus Stanford Type A and B).

Takeda R, Sato F, Yokoyama H, Sasaki K, Oshima N, Kuroda A, Takashima H, Li C, Honda S, Kamiya H. Takeda R, et al. Among authors: oshima n. Ann Vasc Surg. 2022 Feb;79:310-323. doi: 10.1016/j.avsg.2021.08.007. Epub 2021 Oct 12. Ann Vasc Surg. 2022. PMID: 34648855

4

Characteristics of 2-drug regimen users living with HIV-1 in a real-world setting: A large-scale medical claim database analysis in Japan.

Ruzicka DJ, Kamakura M, Kuroishi N, Oshima N, Yamatani M, Yi J, Crawford B, Tsukada K, Oka S. Ruzicka DJ, et al. Among authors: oshima n. PLoS One. 2022 Jun 14;17(6):e0269779. doi: 10.1371/journal.pone.0269779. eCollection 2022. PLoS One. 2022. PMID: 35700215 Free PMC article.

5

A phase I study to evaluate safety, pharmacokinetics, and pharmacodynamics of respiratory syncytial virus neutralizing monoclonal antibody MK-1654 in healthy Japanese adults.

Orito Y, Otani N, Matsumoto Y, Fujimoto K, Oshima N, Maas BM, Caro L, Aliprantis AO, Cox KS, Tokumaru O, Kodama M, Kudo H, Imai H, Uemura N. Orito Y, et al. Among authors: oshima n. Clin Transl Sci. 2022 Jul;15(7):1753-1763. doi: 10.1111/cts.13290. Epub 2022 May 17. Clin Transl Sci. 2022. PMID: 35506164 Free PMC article. Clinical Trial.

6

Safety, Tolerability, and Immunogenicity of V160, a Conditionally Replication-Defective Cytomegalovirus Vaccine, in Healthy Japanese Men in a Randomized, Controlled Phase 1 Study.

Murata S, Oshima N, Iwasa T, Fukao Y, Sawata M. Murata S, et al. Among authors: oshima n. Antibodies (Basel). 2023 Mar 10;12(1):22. doi: 10.3390/antib12010022. Antibodies (Basel). 2023. PMID: 36975369 Free PMC article.

7

A randomized, placebo-controlled study to evaluate the efficacy and safety of adding omarigliptin to insulin therapy in Japanese patients with type 2 diabetes and inadequate glycaemic control.

Kadowaki T, Seino Y, Kaku K, Okamoto T, Kameya M, Sato A, Hirano T, Oshima N, Gantz I, O'Neill EA, Engel SS; Omarigliptin Study 039 Group. Kadowaki T, et al. Among authors: oshima n. Diabetes Obes Metab. 2021 Jun;23(6):1242-1251. doi: 10.1111/dom.14331. Epub 2021 Feb 17. Diabetes Obes Metab. 2021. PMID: 33512755 Free PMC article. Clinical Trial.

8

Letermovir safety and efficacy for cytomegalovirus prophylaxis in adult Japanese kidney transplant recipients: a multicenter, open-label, noncomparative Phase 3 study.

Ishida H, Goto N, Imamura R, Sasaki H, Unagami K, Futamura K, Murata Y, Oshima N, Eto T, Haber B. Ishida H, et al. Among authors: oshima n. Clin Exp Nephrol. 2024 Apr 13. doi: 10.1007/s10157-024-02471-0. Online ahead of print. Clin Exp Nephrol. 2024. PMID: 38615067

9

Switch rates, time-to-switch, and switch patterns of antiretroviral therapy in people living with human immunodeficiency virus in Japan, in a hospital-claim database.

Ruzicka DJ, Kuroishi N, Oshima N, Sakuma R, Naito T. Ruzicka DJ, et al. Among authors: oshima n. BMC Infect Dis. 2019 Jun 10;19(1):505. doi: 10.1186/s12879-019-4129-6. BMC Infect Dis. 2019. PMID: 31182050 Free PMC article.

10

Montelukast in the treatment of perennial allergic rhinitis in paediatric Japanese patients; an open-label clinical trial.

Okubo K, Inoue Y, Numaguchi H, Tanaka K, Saito I, Oshima N, Matsumoto Y, Prohn M, Mehta A, Nishida C, Philip G. Okubo K, et al. Among authors: oshima n. J Drug Assess. 2016 Sep 19;5(1):6-14. doi: 10.1080/21556660.2016.1209507. eCollection 2016. J Drug Assess. 2016. PMID: 27785374 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

13 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year